NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

The effect of decalcification on in situ hybridization.

Author(s): Arber JM, Weiss LM, Chang KL, Battifora H, Arber DA

Publication: Mod Pathol, 1997, Vol. 10, Page 1009-14

PubMed ID: 9346180 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of decalcifying agent and fixation duration on in situ hybridization (ISH) staining in 25 tissue types.

Conclusion of Paper

Versenate-decalcified specimens displayed the most intense and consistent staining. S/P-decalcified specimens were much more variable but still showed acceptable staining in most specimens. In contrast, RBD-decalcified specimens displayed only weak staining. Formalin-fixation duration and tissue type did not have any clear effects.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of decalcifying agent and fixation duration on ISH staining. Non malignant adrenal gland, brain, breast, colon, heart, kidney, liver, lung, lymph, nerve, pancreas, prostate, skin, skeletal muscle, spleen, stomach, thyroid, and uterus as well as lymphoma, melanoma, carcinoid tumor, undifferentiated sarcoma, and angiosarcoma specimens were compared.

    Summary of Findings:

    Staining of versenate-decalcified specimens was positive in 93% of specimens with 72% staining equal to or more intensely than non-decalcified controls. Staining of S/P-decalcified specimens was more variable, and only 49% of specimens had staining more intense or equal to non-decalcified controls. RBD-decalcified specimens had very low staining with only 8% staining equally to or more intensely than non-decalcified controls and 25% not staining at all. Formalin-fixation duration and tissue type did not have any clear effects.

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Lymphoma
    • Neoplastic - Sarcoma
    • Neoplastic - Carcinoma
    • Neoplastic - Melanoma
    • Neoplastic - Benign
    • Autopsy
    Platform:
    AnalyteTechnology Platform
    RNA In situ hybridization
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Analyte Extraction and Purification Decalcification solution/ duration Versenate (EDTA-based)
    S/P Decal (HCl based)
    RBD (HCl based)
    Biospecimen Preservation Time in fixative 6 h
    24 h
    72 h
    Biospecimen Acquisition Biospecimen location Adrenal gland
    Breast
    Brain
    Colon
    Heart
    Kidney
    Liver
    Lung
    Lymph
    Nerve
    Pancreas
    Prostate
    Skin
    Skeletal muscle
    Spleen
    Stomach
    Thyroid
    Uterus

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...